Furthermore, clinicopathological analysis revealed that low-expression of UBC13 was significantly correlated to poorer prognostic factors like the high-grade of the tumor, larger volume of ascitic fluid, and suboptimal primary surgery. The gene discussed is UBE2N; the disease is neoplasm.